Rebecca Fritz
San Antonio, TXNPI 1548716673
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Lilly USA, LLC at 25.0% of the total. Reporting peaked in 2024 at $783 and has fallen 51.8% since, to $378 in 2025.
Across 102 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$562
- AstraZeneca$518
- Amgen$266
- Bausch Health US, LLC$231
- Novo Nordisk$150
- Bayer$137
- plus $380 from 11 others
What the payments were for
- Food & beverage$2,243100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 31 | $562 |
| AstraZeneca | 11 | $518 |
| Amgen | 10 | $266 |
| Bausch Health US, LLC | 13 | $231 |
| Novo Nordisk | 8 | $150 |
| Bayer | 8 | $137 |
| Pfizer | 4 | $76 |
| Boehringer Ingelheim | 3 | $62 |
| Idorsia Pharmaceuticals US Inc | 4 | $60 |
| GSK | 3 | $56 |
| Alk-abello, Inc | 1 | $23 |
| Abbott | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Novartis | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 22 | $34 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.